C

Co-Diagnostics
D

CODX

0.25180
USD
-0.00
(-0.44%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
8,488,815
أصول ذات صلة
A
AEMD
-0.02000
(-1.59%)
1.24000 USD
B
BNGO
0.18000
(5.90%)
3.23000 USD
I
IBIO
0.14970
(26.14%)
0.72230 USD
I
INO
0.22500
(15.31%)
1.69500 USD
L
LAKE
0.865
(6.13%)
14.975 USD
MRNA
MRNA
1.230
(4.80%)
26.880 USD
N
NVAX
0.35500
(4.18%)
8.84000 USD
O
OPK
0.02500
(1.89%)
1.35000 USD
V
VIR
0.21000
(4.82%)
4.56500 USD
المزيد
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.